Clinical Trials: Systemic Lupus Erythematosus

Arizona

Tempe; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

California

Los Angeles; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Los Angeles; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Palo Alto; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

San Leandro; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

San Leandro; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Connecticut

Farmington; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Florida

Boca Raton; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Miami; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Tampa; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Georgia

Atlanta; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Augusta; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Idaho

Boise; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Illinois

Chicago; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Kansas

Kansas City; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Louisiana

New Orleans; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Maryland

Baltimore; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Chevy Chase; The Center for Rheumatology and Bone Research - Chevy Chase, MD
Do you have Systemic Lupus Erythematosus?

Laurel; The Center for Rheumatology and Bone Research - Laurel, MD
Do you have Systemic Lupus Erythematosus?

Rockville; The Center for Rheumatology and Bone Research - Rockville, MD
Do you have Systemic Lupus Erythematosus?

Wheaton; The Center for Rheumatology and Bone Research - Wheaton, MD
Do you have Systemic Lupus Erythematosus?

Massachusetts

Boston; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Boston; BWH - Brigham and Women's Hospital
A randomised, double-blind, placebo-controlled, multicenter prospective dose-finding Phase II/III study with atacicept given subcutaneously to subjects having recently experienced a flare of systemic lupus erythematosus (SLE)

Michigan

Ann Arbor; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Minnesota

Rochester; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Missouri

St Louis; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

New Hampshire

Lebanon; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

New York

Lake Success; Biomedical Research Alliance of New York
Belimumab in subjects with SLE - Adults

Lake Success; Biomedical Research Alliance of New York
Systemic Lupus Erythematosus (SLE) - Adults

Lake Success; Biomedical Research Alliance of New York
People with Systemic Lupus Erythematosis (SLE) are asked to participate in a research study being conducted by North Shore Long Island Jewish Health System.

Lake Success; Biomedical Research Alliance of New York
Membranous Nephropathy Secondary to Systemic Lupus Erythematosus (SLE) - Adults

Manhasset; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Manhasset; Biomedical Research Alliance of New York
Systemic Lupus Erythematosus (SLE) - Adults

Manhasset; Biomedical Research Alliance of New York
Systemic Lupus Erythematosus (SLE) - Adults

Manhasset; Biomedical Research Alliance of New York
Systemic Lupus Erythematosus (SLE) - Adults

Manhasset; Biomedical Research Alliance of New York
Systemic Lupus Erythematosus (SLE) - Adults and minors

Manhasset; Biomedical Research Alliance of New York
Belimumab in subjects with SLE

Manhasset; Biomedical Research Alliance of New York
Systemic Lupus Erythematosus

Manhasset; Biomedical Research Alliance of New York
Systemic Lupus Erythematosus (SLE) - Adults

New York; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

New York; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Orchard Park; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Rochester; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

North Carolina

Chapel Hill; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Charlotte; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Charlotte; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Durham; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Wilmington; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Wilmington; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Ohio

Cincinnati; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Cincinnati; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Cleveland; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Columbus; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Oregon

Portland; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Portland; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Pennsylvania

Bethlehem; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Bethlehem; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Philadelphia; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Philadelphia; University of Pennsylvania Health System
Do you have Lupus?

South Carolina

Charleston; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Charleston; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Tennessee

Memphis ; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Texas

Amarillo; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Amarillo; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Dallas; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Dallas; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

El Paso; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Houston; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Houston; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Mesquite; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

San Antonio; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Sugar Land; Texas Research Center, LLP
Have you been diagnosed with Systemic Lupus Erythematosus (SLE)?

Temple; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Temple; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Washington

Vancouver ; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Washington, DC

Washington; The Center for Rheumatology and Bone Research - Washington, DC
Do you have Systemic Lupus Erythematosus?

Washington; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

International

Buenos Aires , Argentina; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Buenos Aires , Argentina; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Córdoba, Argentina; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

San Juan, Argentina; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

San Miguel De Tucuman, Argentina; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

San Miguel De Tucuman, Argentina; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Tucuman, Argentina; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Belo Horizonte, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Belo Horizonte, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Brasilia, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Brasilia, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Curitiba, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Curitiba, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Fortaleza, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Fortaleza, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Goiania, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Goiania, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Marilia, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Porto Alegre, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Porto Alegre, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Recife, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Recife, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Ribeirão Preto, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Ribeirão Preto, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Rio De Janeiro, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Rio De Janeiro, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Sao Paulo, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Sao Paulo, Brazil; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Pleven, Bulgaria; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Pleven, Bulgaria; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Sofia, Bulgaria; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Sofia, Bulgaria; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

London, ON, Canada; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Scarborough, ON, Canada; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Sherbrooke, QC, Canada; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Toronto, ON, Canada; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Toronto, ON, Canada; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Vancouver, BC, Canada; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Concepcion, Chile; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Concepcion, Chile; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Puente Alto, Chile; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Puente Alto, Chile; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Santiago, Chile; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Santiago, Chile; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Beijing, China; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Beijing, China; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Guangzhou, China; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Guangzhou, China; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Harbin, China; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Harbin, China; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Hong Kong, China; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Hong Kong, China; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Jinan, China; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Jinan, China; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Nanjing, China; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Nanjing, China; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Nanning, China; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Shanghai, China; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Shanghai, China; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Shenyang, China; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Shenyang, China; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Suzhou, China; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Wuhan, China; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Wuhan, China; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Barranquilla, Colombia; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Barranquilla, Colombia; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Bogota, Colombia; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Bogota, Colombia; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Bucaramanga, Colombia; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Bucaramanga, Colombia; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Medellin, Colombia; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Medellin, Colombia; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Cartago, Costa Rica; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Cartago, Costa Rica; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

San José, Costa Rica; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

San José, Costa Rica; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Creteil, France; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Le Kremlin-Bicetre, France; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Lille, France; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Lille, France; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Paris, France; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Strasbourg, France; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Strasbourg, France; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Bad Abbach, Germany; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Bad Abbach, Germany; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Bad Bramstedt , Germany; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Bad Bramstedt , Germany; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Berlin, Germany; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Düsseldorf, Germany; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Düsseldorf, Germany; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Erlangen, Germany; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Erlangen, Germany; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Hamburg, Germany; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Hamburg, Germany; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Hannover, Germany; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Heidelberg, Germany; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Tübingen, Germany; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Tübingen, Germany; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Budapest, Hungary; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Budapest, Hungary; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Debrecen, Hungary; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Debrecen, Hungary; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Pecs, Hungary; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Jakarta, Indonesia; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Malang, Indonesia; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Medan, Indonesia; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Johor Bahru, Malaysia; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Kuala Lumpur, Malaysia; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Kuching, Malaysia; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Kuching, Malaysia; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Nilai, Negeri Sembilan, Malaysia; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Chihuahua, Mexico; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Guadalajara, Mexico; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Guadalajara, Mexico; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Mexico City, Mexico; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Mexico City, Mexico; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Obregon, Mexico; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Obregon, Mexico; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

San Luis Potosi, Mexico; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

San Luis Potosi, Mexico; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Amsterdam, Netherlands; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Amsterdam, Netherlands; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Nijmegen, Netherlands; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Callao, Peru; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Callao, Peru; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Lima, Peru; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Lima, Peru; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Cebu City, Philippines; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Cebu City, Philippines; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Iloilo City, Philippines; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Manila, Philippines; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Quezon City, Philippines; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Quezon City, Philippines; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Bydgoszcz, Poland; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Bydgoszcz, Poland; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Krakow, Poland; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Lodz, Poland; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Lublin, Poland; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Szczecin, Poland; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Szczecin, Poland; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Warszawa, Poland; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Wroclaw, Poland; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Almada, Portugal; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Almada, Portugal; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Lisboa, Portugal; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Lisboa, Portugal; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Porto, Portugal; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Porto, Portugal; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Bucharest, Romania; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Iasi, Romania; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Kazan, Russian Federation; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Moscow, Russian Federation; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Moscow, Russian Federation; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

St Petersburg, Russian Federation; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

St Petersburg, Russian Federation; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Yaroslavl, Russian Federation; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Yaroslavl, Russian Federation; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Singapore, Singapore; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Singapore, Singapore; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Cape Town, South Africa; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Cape Town, South Africa; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Durban, South Africa; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Durban, South Africa; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Barcelona, Spain; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Madrid, Spain; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Malaga, Spain; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Sevilla, Spain; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Sevilla, Spain; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Huddinge, Sweden; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Linkoeping, Sweden; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Lund, Sweden; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Stockholm, Sweden; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Stockholm, Sweden; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Uppsala, Sweden; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Kaohsiung, Taiwan; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Taichung, Taiwan; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Taoyuan, Taiwan; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Bangkok, Thailand; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Bangkok, Thailand; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Chiang Mai, Thailand; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Khon Kaen, Thailand; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Pathumthani, Thailand; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Phitsanulok, Thailand; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Songkhla, Thailand; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Adana, Turkey; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Ankara, Turkey; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Istanbul, Turkey; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Izmir, Turkey; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Birmingham, United Kingdom; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Birmingham, United Kingdom; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Cambridge, United Kingdom; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Cambridge, United Kingdom; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Derby, United Kingdom; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Derby, United Kingdom; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Leeds, United Kingdom; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Leeds, United Kingdom; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

London, United Kingdom; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

London, United Kingdom; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Manchester, United Kingdom; Research Site:
A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.

Manchester, United Kingdom; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Newcastle upon Tyne, United Kingdom; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.

Stoke-on-Trent, United Kingdom; Research Site:
A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.